NuGEN Names Dr. Lutz Kirchrath Managing Director of European Field Operations
Company expands presence in EU to meet rapidly growing demand
San Carlos, Calif.—April 7, 2009—NuGEN Technologies, Inc., a leader in nucleic acid sample preparation announced today it has named Dr. Lutz Kirchrath to serve as managing director of European field operations reporting to Dr. Sue Pandey, vice president of field operations. Dr. Kirchrath will lead both sales and technical support functions.
Dr. Kirchrath's appointment will increase the company's European presence, enhance customer satisfaction, and foster productive collaborations. Explained Pandey, "Europe is a rapidly growing market for NuGEN. Expansion of our direct presence is a strategic investment to provide even better support for the European community and to ensure our continued growth in 2009 and beyond."
Dr. Kirchrath was most recently European pharmaceutical district manager for Affymetrix where he developed targeted sales and business development strategies, and managed cross-functional workflows between sales, marketing, field support, customer service, and finance teams. Prior to Affymetrix, Dr. Kirchrath spent nearly five years in sales development and applications support positions with Amersham Pharmacia Biotech in Freiburg, Germany.
"I am excited to join the company that has revolutionized nucleic acid sample preparation enabling life science researchers to mine precious samples on various genomic analysis platforms," Kirchrath stated. "In addition, I will be able to continue to drive the customer focus that NuGEN has made a priority and bring innovative solutions to scientists' toughest challenges in clinical research, expression profiling, and biomarker and signature discovery."
Kirchrath earned his doctorate in microbiology and molecular genetics and his diploma in biology magna cum laude from the Institute for Microbiology at the Heinrich-Heine Universitat, Dusseldorf. He is a native of Dusseldorf, Germany.
NuGEN Technologies, Inc. (www.nugeninc.com), based in San Carlos, CA, is focused on the development and commercialization of sensitive, rapid, and high-throughput amplification and sample preparation systems to enable the comprehensive analysis and discovery of biological mechanisms, cellular responses, and disease pathologies.
NuGEN, Ovation, SPIA, Ribo-SPIA, WT-Ovation, FL-Ovation, and Imagine More From Less are trademarks or registered trademarks of NuGEN Technologies, Inc. Other marks are the property of their respective owners.